Skip to content

Clinical trials

Phase 1 Squamous Cell Carcinoma of Head and Neck trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1 Country / region: United States Clear all

355 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
20024
20032
20044
20054
20062
20075
20088
20094
20104
20117
20124
201311
20148
201522
201612
201717
201824
201924
202031
202123
202222
202329
202424
202520
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed157
Terminated80
Recruiting62
Active, not recruiting35
Withdrawn10
Unknown status6
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
AbbVie13
Pfizer11
M.D. Anderson Cancer Center8
Vanderbilt-Ingram Cancer Center8
Dana-Farber Cancer Institute7
Case Comprehensive Cancer Center6
Novartis Pharmaceuticals6
Presage Biosciences6
Bayer5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck355
Carcinoma, Non-Small-Cell Lung137
Head and Neck Neoplasms86
Melanoma80
Colorectal Neoplasms68
Carcinoma, Renal Cell63
Stomach Neoplasms55
Ovarian Neoplasms52
Triple Negative Breast Neoplasms52
Breast Neoplasms51

Trials

Showing 1 to 25 of 355. Each trial links to its page on Pharma Observatory.

255 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.